Related Experiment Videos
Platelet MAO in patients with idiopathic pain disorders
Abstract:
Patients with idiopathic pain syndromes have been compared to healthy volunteers and patients with neurogenic pain syndromes as concerns the activity of the enzyme monoamine oxidase (MAO) in thrombocytes. In both patients with idiopathic pain syndromes and in patients with neurogenic pain syndromes an increased frequency of patients with low platelet MAO activity was found. As low platelet MAO activity has been suggested to reflect low central serotoninergic activity the results are in line with findings of reduced concentrations of the serotonin metabolite 5-HIAA in CSF in patients with idiopathic pain syndromes. The results would also give some support for the suggestion that idiopathic pain syndromes might be a variant of depressive disease.
Insights
Patients with idiopathic pain syndromes show low platelet monoamine oxidase (MAO) activity, similar to neurogenic pain patients. This suggests reduced central serotonergic activity and links idiopathic pain to depression.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Idiopathic pain syndromes (IPS) lack clear causes.
- Monoamine oxidase (MAO) enzyme activity is implicated in neurotransmitter regulation.
- Platelet MAO activity may reflect central serotonergic function.
Purpose of the Study:
- To compare platelet MAO activity in patients with IPS, neurogenic pain, and healthy controls.
- To investigate the link between MAO activity and serotonergic pathways in IPS.
- To explore the potential relationship between IPS and depressive disorders.
Main Methods:
- Enzyme activity assay for monoamine oxidase (MAO) in thrombocytes (platelets).
- Comparison of MAO activity levels across three groups: IPS patients, neurogenic pain patients, and healthy volunteers.
Main Results:
- An increased frequency of low platelet MAO activity was observed in both IPS and neurogenic pain patient groups compared to controls.
- Low platelet MAO activity in IPS patients aligns with reduced cerebrospinal fluid (CSF) 5-hydroxyindoleacetic acid (5-HIAA) levels, a serotonin metabolite.
Conclusions:
- Reduced platelet MAO activity is a potential biomarker for IPS and neurogenic pain syndromes.
- Findings support the hypothesis of reduced central serotonergic activity in IPS.
- Results suggest that IPS may represent a variant of depressive disease.